Psychiatry as clinical neuroscience: present and future

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A review of literature is devoted to consideration of the theoretical studies in modern psychiatry as a clinical representative of neurosciences. It discusses the development of a personalized approach in psychiatry, the training of psychiatrists in neurobiology, the prospects for transferring the achievements of psychiatric science into clinical practice, and new principles of systematization of mental disorders.

About the authors

Nataliia N. Petrova

Saint Petersburg State University

Author for correspondence.
Email: petrova_nn@mail.ru

MD, professor, head of the department of psychiatry and narcology

Russian Federation, 199034, St. Petersburg, University embankment, 7/9

Maria V. Dorofeikova

Sechenov Institute of Evolutionary Physiology and Biochemistry

Email: mvdorofeykova@mail.ru

PhD, researcher

Russian Federation, 194223, Saint-Petersburg, Toreza Ave, 44

References

  1. Ryan T.A., Jin Y. Editorial overview: Molecular neuroscience. Curr. Opin. Neurobiol. 2019; 57: III–VI. doi: 10.1016/j.conb.2019.06.002.
  2. Lorusso L., Piccolino M., Motta S. et al. Neuroscience without borders: Preserving the history of neuroscience. Eur. J. Neurosci. 2018; 48: 2099–2109. doi: 10.1111/ejn.14101.
  3. Arbuckle M.R., Travis M.J., Ross D.A. Integrating a neuroscience perspective into clinical psychiatry today. JAMA Psychiatry. 2017; 74 (4): 313–314.
  4. Fung L.K., Akil M., Widge A. et al. Attitudes towards neuroscience education among psychiatry residents and fellows. Acad. Psychiatry. 2014; 38 (2): 127–134.
  5. Hassan T., Prasad B., Meek B.P., Modirrousta M. Attitudes of psychiatry residents in Canadian Universities toward neuroscience and its implication in psychiatric practice. Can. J. Psychiatry. 2020; 65 (3): 174–183. doi: 10.1177/0706743719881539.
  6. Ross D.A., Travis M.J., Arbuckle M.R. The future of psychiatry as clinical neuroscience: why not now? JAMA Psychiatry. 2015; 72 (5): 413–414.
  7. Benjamin S. Educating psychiatry residents in neuropsychiatry and neuroscience. Int. Rev. Psychiatry. 2013; 25 (3): 265–275. doi: 10.3109/09540261.2013.786689.
  8. Lüscher C. The future of clinical neuroscience: A view from the bench. Clin. Translat. Neurosci. 2018; 2 (2): 1–3. doi: 10.1177/2514183X18781315.
  9. Perna G., Nemeroff C.B. Personalized medicine in psychiatry: Back to the future. Personalized Med. Psychiatry. 2017; 1–2: 1–84.
  10. Fulford K.W.M., Bortolotti L., Broome M. Taking the long view: an emerging framework for translational psychiatric science. World Psychiatry. 2014; 13: 110–117. doi: 10.1002/wps.20139.
  11. Власова О.А. Философия психиатрии: четверть века дискуссий. Неврологич. вестн. 2020; LII (2): 12–19. [Vlasova O.A. Filosofiya psihiatrii: chetvert’ veka diskussij. Nevrologicheskij vestnik. 2020; LII (2): 12–19. (In Russ.)]
  12. Yahata N., Kasai K., Kawato M. Computational neuroscience approach to biomarkers and treatments for mental disorders. Psychiatry Clin. Neurosci. 2017; 71: 215–237.
  13. Young K.D., Zotev V., Phillips R. et al. Amygdala real-time functional magnetic resonance imaging neurofeedback for major depressive disorder: A review. Psychiatry Clin. Neurosci. 2018; 72: 466–481.
  14. Liu Y.N., Lu S.Y., Yao J. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. Psychiatry Clin. Neurosci. 2017; 71: 579–599.
  15. Kato T., Kanba S. Making psychiatry a clinical neuroscience-based medicine. Psychiatry Clin. Neurosci. 2019; 73: 1.
  16. Krueger R.F., Kotov R., Watson D. et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry. 2018; 17 (3): 282–293.
  17. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry. 2012; 17: 1174–1179.
  18. Insel T., Cuthbert B., Garvey M. et al. Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. Am. J. Psychiatry. 2010; 167: 748–751.
  19. Cuthbert B.N. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry. 2014; 13: 28–35.
  20. Krueger R.F., Markon K.E. A dimensional-spectrum model of psychopathology: progress and opportunities. Arch. Gen. Psychiatry. 2011; 68 (1): 10–11.
  21. Koudys J.W., Traynor J.M., Rodrigo A.H. et al. The NIMH Research Domain Criteria (RDoC) Initiative and its implications for research on personality disorder. Curr. Psychiatry Rep. 2019; 21: 37.
  22. Wium-Andersen I.K., Vinberg M., Kessing M.V., McIntyre R.S. Personalized medicine in psychiatry. Nordic J. Psychiatry. 2017; 71 (1): 12–19. doi: 10.1080/08039488.2016.1216163.
  23. Greenwood T.A., Shutes-David A., Tsuang D.W. Endophenotypes in schizophrenia: Digging deeper to identify genetic mechanisms. J. Psychiatr. Brain Sci. 2019; 4 (2): e190005. doi: 10.20900/jpbs.20190005.
  24. Holmes A.J., Patrick L.M. The myth of optimality in clinical neuroscience. Trends Cogn. Sci. 2018; 22 (3): 241–257.
  25. Thompson P.M., Jahanshad N., Ching C.R.K. et al. ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl. Psychiatry. 2020; 10 (1): 100. doi: 10.1038/s41398-020-0705-1.
  26. Baker J.T., Holmes A.J., Masters G.A. et al. Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry. 2014; 71 (2): 109–118. doi: 10.1001/jamapsychiatry.2013.3469.
  27. Datta D., Arnsten A.F.T. Unique molecular regulation of higher-order prefrontal cortical circuits: Insights into the neurobiology of schizophrenia. ACS Chem. Neurosci. 2018; 9 (9): 2127–2145. doi: 10.1021/acschemneuro.7b00505.
  28. Sheffield J.M., Kandala S., Tamminga C.A. et al. Transdiagnostic associations between functional brain network integrity and cognition. JAMA Psychiatry. 2017; 74 (6): 605–613. doi: 10.1001/jamapsychiatry.2017.0669.
  29. Kimoto S., Makinodan M., Kishimoto T. Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap. Neurobiol. Dis. 2019; 131: 104315. doi: 10.1016/j.nbd.2018.10.022.
  30. Yang C., Qi A., Yu H. et al. Different levels of facial expression recognition in patients with first-episode schizophrenia: A functional MRI study. Gen. Psychiatr. 2018; 31 (2): e000014.
  31. Kircher T., Bröhl H., Meier F., Engelen J. Formal thought disorders: from phenomenology to neurobiology. Lancet Psychiatry. 2018; 5 (6): 515–526. doi: 10.1016/S2215-0366(18)30059-2.
  32. Lo M.-C., Widge A.S. Closed-loop neuromodulation systems: Next-generation treatments for psychiatric illness. Int. Rev. Psychiatry. 2017; 29 (2): 191–204.
  33. Hsin H., Fromer M., Peterson B. et al. Transforming psychiatry into data-driven medicine with digital measurement tools. NPJ Digit. Med. 2018; 1: 37.
  34. Al Dahhan N.Z., De Felice F.G., Munoz D.P. Potentials and Pitfalls of Cross-Translational Models of Cognitive Impairment. Front. Behav. Neurosci. 2019; 13: 48. doi: 10.3389/fnbeh.2019.00048.

Copyright (c) 2021 Petrova N.N., Dorofeikova M.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies